Act-Hib (Hib)

Act-Hib (Hib) is a vaccine designed to protect against Haemophilus influenzae type b (Hib) infections. This conjugate vaccine uses tetanus toxoid to enhance immune response, suitable for intramuscular or subcutaneous use.

Act-Hib (Hib) is primarily used to prevent invasive diseases caused by Haemophilus influenzae type b, such as meningitis and pneumonia. It is often administered to infants and young children as part of routine vaccination schedules to build immunity against Hib infections.

Common effects of Act-Hib (Hib) may include mild redness, swelling, or tenderness at the injection site. Some individuals might experience low-grade fever or mild irritability following vaccination. These effects are generally short-lived.

Act-Hib (Hib) should be administered by healthcare professionals trained in vaccination procedures. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. Always inform your healthcare provider about any existing medical conditions before vaccination.

Act-Hib (Hib) is generally safe when used as directed. However, it should not be mixed with other vaccines in the same syringe unless specifically advised by a healthcare professional. Always consult your healthcare provider for personalized advice regarding potential interactions.